Postnatal corticosteroids for transient tachypnoea of the newborn

Given the paucity and very low quality of the available evidence (single RCT; N=49), the benefits and harms of postnatal administration of either inhaled or systemic corticosteroids for the management of transient tachypnoea of the newborn, could not be determined.


Cochrane Database of Systematic Reviews